JAG1 and ovarian carcinoma: Intriguingly, higher JAG1 expression was exclusively observed in cisplatin–resistant ovarian cancer cell lines (C13*, SKOV3 and A2780cp) compared with their corresponding cisplatin-sensitive cell lines (OV2008 and A2780s) (Fig. 4C).